2. The PSAEFI in Brazil has certain features that distinguish it from similar systems in developed countries such as the United States and those in the European Union [4] and [26]. Their objectives are less comprehensive, and have operated exclusively under the auspices of the NIP [12] and [24] and are not formally linked to a regulatory health agency. Nevertheless, see more a committee, created in 2008, has been charged with fostering joint activities and promoting cooperation between NIP and the regulatory
health agency in terms of the sharing information related AEFIs in order to improve the vaccine safety in Brazil. The Brazilian passive SAEFI system, despite its relatively lower degree of complexity, is capable of adequately monitoring vaccine safety, as well as being capable of responding promptly to the questions and apprehensions of the populace. One example of such public concern is provided by the DTwP/Hib vaccine. Soon after the introduction of this vaccine into the routine Brazilian vaccination schedule, there were rumors that the incidence of severe AEFIs, especially HHEs, had increased in various states. The NIP staff immediately launched a study to investigate the questions raised,
ultimately proving that such fears were unfounded [13]. This indicates the usefulness and timeliness of the PSAEFI, as well as the importance, in such situations, of developing epidemiological studies to complement the PSAEFI data [26]. Despite the limitations of passive surveillance [26], the results obtained in the present study are consistent with those found in Autophagy Compound Library datasheet the literature. The interval between the administration of the vaccine and the occurrence of the AEFI, especially for HHEs and convulsions, was similar to that described in studies evaluating
the DTwP or DTwP/Hib vaccine [13] and [25]. Our finding that the risk of AEFI with DTwP/Hib vaccine decreases progressively over the course of the vaccination schedule is also in keeping with the findings of other authors [13]. The proportion of severe AEFIs found in the present study should be interpreted Edoxaban with caution, since it is considerably higher than that found in other studies employing passive surveillance [27] and [28]. Given that the reactogenicity of Brazilian DTwP/Hib vaccine is comparable with the same vaccine registered in countries such as Israel [29] and [30], this discrepancy can be attributed to the case definition adopted in Brazil [23], which downplays mild events and late-onset AEFIs, resulting in an overestimation of the proportion of severe events [13], [24] and [28]. The use of paracetamol, which the NIP recommends for children with a history of AEFI, might decrease the incidence of mild AEFI. However the frequency of paracetamol use in Brazil is unknown [31]. The number, probably underestimated, of cases treated in hospitals, should not be overlooked.
Related posts:
- Similar to C par vum, T gondii features a proportionally large
- Samples were gated to distinguish compact debris and doublets by
- The authors
of the Latin American study noted that in Bra - The resulting detoxified whole cell diphtheria–tetanus–pertussis
- This represented the average time when a case would become affect